Knee Arthrofibrosis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2024-09-23
Clinical Trial Update: Losartan Use to Mitigate Arthrofibrosis Following Total Joint Arthroplasty [Phase 4]
Phase 4 trial evaluating losartan to mitigate knee arthrofibrosis after total knee arthroplasty has been withdrawn.